Signal from the log
Beacon Biosignals
97 M$ · Series B · United States · Diagnostics
Société américaine qui fabrique un électroencéphalogramme portable, porté à domicile, couplé à une analyse automatique du signal neurologique. Elle vend ses données aux essais cliniques et au diagnostic, dans un domaine où la mesure du cerveau supposait jusqu'ici une nuit à l'hôpital. La série B a été relevée à plus de 97 M$.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 97 M$
- Stage
- Series B
- Country
- United States
- Sector
- Diagnostics
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by JSL Health , Palo Santo VC , Kicker Ventures , Samsung Next , with Innoviva , GV , S32 , Catalio Capital Management , General Catalyst , Logos Capital , Casdin Capital , Indicator Ventures
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.